Avecho Biotechnology Limited (ASX:AVE)
0.0060
-0.0010 (-14.29%)
Aug 28, 2025, 3:00 PM AEST
Avecho Biotechnology Revenue
In the year 2024, Avecho Biotechnology had annual revenue of 1.13M AUD with 139.19% growth. Avecho Biotechnology had revenue of 820.49K in the half year ending December 31, 2024, with 121.14% growth.
Revenue
1.13M
Revenue Growth
+139.19%
P/S Ratio
13.79
Revenue / Employee
92.04K
Employees
15
Market Cap
19.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.13M | 659.12K | 139.19% |
Dec 31, 2023 | 473.55K | -655.71K | -58.07% |
Dec 31, 2022 | 1.13M | 335.66K | 42.30% |
Dec 31, 2021 | 793.60K | 408.97K | 106.33% |
Dec 31, 2020 | 384.63K | -3.85M | -90.92% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 9.16M |